Basic Study Open Access
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Jan 26, 2016; 8(1): 89-97
Published online Jan 26, 2016. doi: 10.4330/wjc.v8.i1.89
Bicuspid aortic valve hemodynamics does not promote remodeling in porcine aortic wall concavity
Samantha K Atkins, Alison N Moore, Department of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN 46556, United States
Philippe Sucosky, Department of Mechanical and Materials Engineering, Wright State University, Dayton, OH 45435, United States
Author contributions: Atkins SK performed the experiments and biological assays, and conducted the analysis; Moore AN performed the biological assays; Atkins SK and Sucosky P wrote the paper.
Supported by National Science Foundation, Nos. CMMI-1148558 and CMMI-1550144.
Institutional review board statement: Not applicable (no human/animal subjects).
Institutional animal care and use committee statement: Not applicable (no human/animal subjects).
Conflict-of-interest statement: The authors declare no conflict of interest.
Data sharing statement: Complete dataset and statistical analyses available from the corresponding author at philippe.sucosky@wright.edu.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Philippe Sucosky, PhD, FAHA, Department of Mechanical and Materials Engineering, Wright State University, 257 Russ Engineering Center, 3640 Colonel Glenn Highway, Dayton, OH 45435, United States. philippe.sucosky@wright.edu
Telephone: +1-937-7754650 Fax: +1-937-7755082
Received: September 27, 2015
Peer-review started: October 3, 2015
First decision: October 27, 2015
Revised: October 30, 2015
Accepted: December 3, 2015
Article in press: December 4, 2015
Published online: January 26, 2016
Processing time: 121 Days and 15.8 Hours

Abstract

AIM: To investigate the role of type-I left-right bicuspid aortic valve (LR-BAV) hemodynamic stresses in the remodeling of the thoracic ascending aorta (AA) concavity, in the absence of underlying genetic or structural defects.

METHODS: Transient wall shear stress (WSS) profiles in the concavity of tricuspid aortic valve (TAV) and LR-BAV AAs were obtained computationally. Tissue specimens excised from the concavity of normal (non-dilated) porcine AAs were subjected for 48 h to those stress environments using a shear stress bioreactor. Tissue remodeling was characterized in terms of matrix metalloproteinase (MMP) expression and activity via immunostaining and gelatin zymography.

RESULTS: Immunostaining semi-quantification results indicated no significant difference in MMP-2 and MMP-9 expression between the tissue groups exposed to TAV and LR-BAV AA WSS (P = 0.80 and P = 0.19, respectively). Zymography densitometry revealed no difference in MMP-2 activity (total activity, active form and latent form) between the groups subjected to TAV AA and LR-BAV AA WSS (P = 0.08, P = 0.15 and P = 0.59, respectively).

CONCLUSION: The hemodynamic stress environment present in the concavity of type-I LR-BAV AA does not cause any significant change in proteolytic enzyme expression and activity as compared to that present in the TAV AA.

Key Words: Bicuspid aortic valve; Fluid shear stress; Aortopathy; Remodeling; Matrix metalloproteinases

Core tip: The bicuspid aortic valve with left-right cusp fusion (LR-BAV) generates a stress overload on the ascending aorta (AA) convexity, which promotes aortic medial degeneration and aortic dilation. While the wall concavity is generally spared from the disease, the protective role of the local hemodynamics has not been demonstrated. This study aimed at comparing matrix metalloproteinase biology in AA concavity tissue subjected to the local hemodynamic stresses generated by a tricuspid aortic valve (TAV) and a LR-BAV. The results suggest that the fluid stresses in the TAV AA and LR-BAV AA concavity result in similar MMP expressions and activities.



INTRODUCTION

The bicuspid aortic valve (BAV) is present in 1%-2% of the general population[1-3] and is the most common cardiac anomaly. Despite its seemingly low incidence, the BAV is responsible for causing more valvular and vascular disease compared to all other congenital heart defects combined[4]. Unlike the normal tricuspid aortic valve (TAV) which consists of three leaflets, the BAV forms with only two[5-7]. While there are different BAV morphogenic phenotypes[8-10], the most common is referred to as the type-I BAV and is characterized by the presence of two cusps of unequal size and one fibrous raphe marking the site of fusion on the larger leaflet[5]. Type-I BAV patients not only have a higher susceptibility to develop valvulopathies that usually require surgical intervention and valvular replacement, they are also associated with increased risk of aortopathies such as aortic dilation, dissection and aneurysm[11-13]. In particular, type-I BAVs with fusion between the left- and right-coronary cusps (LR subtype) has emerged as the most aggressive in terms of risk for secondary aortopathy[14-16]. This subtype tends to result in asymmetric dilation patterns that localize to the convex region of the thoracic ascending aorta (AA) but spare the wall concavity[14,15,17].

Previous clinical studies have demonstrated that the degenerative remodeling of the aortic wall in type-I BAV patients is accompanied by increased expression of matrix metalloproteinase-2 (MMP-2) and MMP-9[16,18-20] in the disease-prone wall convexity relative to the wall concavity[14,15,21]. Those proteolytic enzymes degrade key extracellular matrix components such as collagen and elastin[22]. The respective expression and activity of those enzymes and their tissue inhibitors regulate the balance between extracellular matrix synthesis and resorption[23]. A perturbation of this delicate equilibrium can result in the progressive degeneration of the vascular wall and the loss of vessel wall integrity[24].

Interestingly, type-I LR-BAVs have been shown to generate perturbed hemodynamics characterized by a valvular jet skewed toward the non-coronary leaflet and increased shearing friction force [i.e., wall shear stress (WSS)] on the convexity of the thoracic AA[25-31]. While those observations suggest a role for hemodynamics in the pathogenesis of BAV aortopathy[32-34] and despite the clear evidence for the existence of flow abnormalities in BAV aortic wall regions vulnerable to dilation, the causative effects of those abnormalities on the local weakening of the aortic wall have not been fully established. Underlying challenges hampering the in vivo assessment of this hemodynamic theory include the possible existence of genetic anomalies in the aortic wall, as well as the paucity of hemodynamic data in non-dilated BAV aortas. To circumvent those issues, ex vivo methodologies enabling the replication of the native BAV AA WSS environment on genetically normal and non-dilated AA tissue have been developed.

In our previous ex vivo study[35], we isolated the impact of TAV and LR-BAV hemodynamic stresses on the remodeling of the AA convexity. The WSS environments in the convex region of a TAV AA and a normal (non-dilated) LR-BAV AA were quantified computationally[28,35] and replicated in the laboratory using a shear stress bioreactor[36,37]. The remodeling response of porcine aortic tissue extracted from the AA convexity and exposed to those environments for 48 h was investigated via immunostaining, immunoblotting and zymography. Exposure of normal aortic tissue to BAV AA WSS resulted in increased MMP-2 and MMP-9 expressions and MMP-2 activity but similar fibrillin-1 content relative to the TAV AA WSS treatment. While this study demonstrated the susceptibility of the hemodynamic stresses experienced by the BAV AA convexity to focally mediate aortic medial degradation, the apparent protective effects of the LR-BAV hemodynamics on the AA concavity and the asymmetric development of dilation in the LR-BAV AA require further investigation. Therefore, the objective of the present study was to isolate ex vivo the impact of LR-BAV hemodynamic stresses on the remodeling of the disease-protected AA concavity, with a focus on MMP expression and activity.

MATERIALS AND METHODS
WSS characterization and in vitro generation

The temporal WSS variations experienced by the concave region of a TAV AA and LR-BAV AA were obtained computationally using a previously published and validated fluid-structure interaction (FSI) model of a human aorta subjected to idealized TAV and LR-BAV flows[28]. Briefly, a realistic model of a human aortic arch was reconstructed based on histological slices (Visible Human Project, National Library of Medicine). 3D transient velocity profiles matching physiologic TAV and LR-BAV average flow rates were prescribed at the model inlet. The dynamic WSS profiles experienced by the TAV AA and LR-BAV AA concavity were captured in a rectangular region (dimensions: 8 mm × 15 mm) centered on the wall concavity and located 1 cm above the left-coronary leaflet (Figure 1A). The two WSS waveforms share important similarities both qualitatively and quantitatively, as indicated by their peak values and average magnitude temporal shear magnitude (TSM) over one cardiac cycle (Table 1). Importantly, as compared to the TAV, which generates a nearly perfectly sinusoidal WSS signal, the LR-BAV generates a double negative WSS peak, which tends to lower the signal oscillatory shear index (OSI).

Table 1 Wall shear stress signal characteristics in the concavity of the tricuspid aortic valve and left-right bicuspid aortic valve ascending aorta.
Maximum (Pa)Minimum (Pa)TSM (Pa)OSI
TAV AA WSS3.2-2.750.770.49
LR-BAV AA WSS3.3-3.631.060.18
Figure 1
Figure 1 Ex vivo methodology. A: Temporal wall shear stress (WSS) signals captured computationally in the concavity of the tricuspid aortic valve (TAV) ascending aorta (AA) and left-right bicuspid aortic valve (LR-BAV) AA (adapted from Cao et al[28]); B: Shear stress bioreactor used to condition porcine AA tissue to TAV AA and BAV AA WSS.

The two WSS environments were replicated in the laboratory using our previously described and validated cone-and-plate bioreactor[35,37]. Briefly, the device consists of a cylindrical chamber filled with culture medium and containing a cone rotating above a stationary mounting plate (Figure 1B). The rotation of the cone generates a flow and thus, a WSS on the surface of the plate, whose intensity τ at a radial location r is directly proportional to the cone angular velocity ω:

ω = [(h + rα)/μr]τ (1)

where μ is the dynamic viscosity of the culture medium (0.95 × 10-3 kg/m per second), α is the cone half angle (0.5°), and h is the distance between the cone apex and the mounting plate (200 μm)[36]. The two angular velocity waveforms producing the TAV AA and LR-BAV AA WSS profiles obtained computationally were programmed into the servo drive (Gemini GV6k, Parker Hannafin) controlling the cone motion. The details of this protocol have been previously published[35].

Tissue harvest and preparation

The experiments were conducted on porcine aortas (6-12 mo) acquired from a local abattoir (Martin’s Custom Butchering, Wakarusa, IN, United States) due to their structural similarities with human aortas and their well-characterized antibody specificities. Aortic tissue was harvested after on-site dissection of the hearts within 10 min of slaughter and was transported to the laboratory in sterile, ice-cold Dulbecco’s Phosphate Buffered Saline (PBS, Sigma-Aldrich). This protocol has been previously implemented in our laboratory and has been shown to preserve endothelium integrity and cellular viability[35,36,38]. All subsequent procedures were performed in a sterile flow hood. Upon arrival to the laboratory, the aortas were cut longitudinally in order to expose the inner endothelial surface. Consistent with our previous study on the effects of BAV flow on AA convexity[35], two circular specimen (7-mm diameter) were excised from the AA concavity, 8 and 15 mm above the sinus of the left-coronary leaflet (i.e., region least prone to dilation[14,15,39]). Samples were then randomized into fresh controls and experimental samples. Six samples were mounted to the circular plate using a button suturing technique, which has been shown not to affect the WSS level generated on the tissue[35]. The native orientation of the tissue relative to blood flow was maintained by aligning the longitudinal axis of the samples with the direction of cone motion (i.e., tangential direction). Tissue conditioning to WSS was performed in an incubator maintaining a temperature of 37 °C and a CO2 level of 5% for 48 h (duration sufficient for acute mechanosensitive remodeling processes to become evident in aortic tissue[34,35,40]). The system was continuously perfused with standard culture medium (Dulbecco’s Modified Eagle’s Medium supplemented with 10% fetal bovine serum, 3.7 g/L sodium bicarbonate, 0.05 g/L ascorbic acid, 10% non-essential amino acid solution and 1% penicillin-streptomycin; all from Sigma-Aldrich) at a rate of two bioreactor volumes per hour. The perfusion system was flushed and replenished with fresh medium every 12 h.

Groups

Two experimental groups and one control group were considered to isolate the impact of TAV AA and LR-BAV AA hemodynamics on the acute remodeling response of the AA concavity: (1) fresh porcine tissue excised from the concavity of the ascending aortic wall (control); (2) fresh porcine tissue excised from the concavity of the ascending aortic wall and subjected to the local TAV AA WSS; and (3) fresh porcine tissue excised from the concavity of the ascending aortic wall and subjected to the local BAV AA WSS.

Biological analyses

Following WSS conditioning, the samples were harvested and washed three times with sterile PBS. The samples were then either frozen in optimal cutting medium for future immunostaining analysis flash frozen in liquid nitrogen for future gelatin zymography analysis.

Immunostaining: The OCT blocks were cut into 5-μm sections using a Microm 505E cryostat (Microm International GmbH) and mounted on glass slides. The region occupied by the tissue section was circled with a fluid block pen (Immunotech) after 20 min on a heater at 37 °C. Sections were then rinsed for 20 min in PBS. Blocking [10% Goat Serum (Sigma), 0.2% TritonX-100 (Sigma), 1% dimethyl sulfoxide (Thermo Fisher Scientific)] was performed at room temperature for 1 h. Next, MMP-2 (1:200, EMD Millipore) or MMP-9 (1:200, EMD Millipore) primary antibody was diluted in blocker and slides were incubated overnight at 4 °C with shaking. The following day, PBS was used to rinse the sections 3 times and secondary antibody (1:100, Santa Cruz) was incubated for 2 h at room temperature in PBS. Sections were rinsed 3 more times in PBS for 5 min each before counterstaining with 1 4’,6-Diamindino-2-phenylindole (DAPI, Sigma) and mounted with fluorescence mounting medium (Dako). Coverslipped sections were stored at 4 °C. Fluorescence immunohistochemistry (IHC) performed on a Nikon E600 microscope was used to identify regions positively stained for MMP-2 and MMP-9 on each slide. MMP-2 and MMP-9 expression was assessed semi-quantitatively using ImageJ (National Institutes of Health, Bethesda, MD) over three image fields per sample, following our previously published methodology[38,41-43]. The overall intensity of MMP immunopositive expression was measured and normalized by the total number of cells present over each image field.

Gelatin zymography: Proteolytic activity of enzymes MMP-2 and MMP-9 was quantified using gelatin zymography. The collected supernatant protein content was quantified using a bicinchoninic acid protein assay (BCA, Pierce). Tissue lysates were loaded in equal amounts (20 μg) on a 10% zymogram gel (Bio-Rad). Gels were resolved by sample buffer (Bio-Rad) followed by 1 h incubation in developing buffer (Bio-Rad) at 37 °C and 5% CO2. Stain solution (G-Biosciences) was added at room temperature, then gels were destained in deionized water at room temperature. Gels were scanned and the digital images were converted to 8-bit grayscale images before being processed in ImageJ for densitometric analysis following our previously published protocol[42,43].

Statistical analysis

Consistent with our previous study, each analysis was performed on a sample size of N = 3 and was quantified as mean ± SE. This sample size was shown previously to generate significant biological differences between convexity tissue specimens subjected to TAV and BAV flows[35]. Normalization to the fresh control was performed in all experimental groups. Significance was determined using ANOVA followed by a Bonferroni post-hoc test using the software SAS (SAS Institute Inc). The threshold for statistical significance was set at a P value of 0.05. Those analyses were reviewed by a biomedical statistician (Dr. Ick H Jin, Department of Applied and Computational Mathematics and Statistics, University of Notre Dame, Notre Dame, IN, United States).

RESULTS
TAV and LR-BAV hemodynamic stresses generate similar MMP expression levels in AA concavity tissue

MMP-2 and MMP-9 immunostaining results are shown in Figure 2. In fresh tissue, MMP-2 and MMP-9 expressions were moderate and consistently localized in the medial layer (Figure 2A). While MMP-2 and MMP-9 were also detected in the same region in specimens subjected to WSS, MMP-9 expression was reduced in the samples subjected to BAV AA WSS. Semi-quantification of the IHC images (Figure 2B) revealed statistically similar MMP-2 expression across the different groups (TAV AA WSS: 1.2-fold increase vs control, P = 0.73; BAV AA WSS: 1.1-fold increase vs controls, P = 0.95) and no statistical difference between the two experimental groups subjected to WSS (P = 0.80). While MMP-9 semi-quantification indicated a significant reduction in MMP-9 expression in tissue exposed to BAV AA WSS (0.3-fold increase vs control, P = 0.01), it revealed no statistical difference between the fresh controls and the specimens subjected to TAV AA WSS (0.6-fold increase vs control, P = 0.20) or between the two conditioned groups (P = 0.19).

Figure 2
Figure 2 Matrix metalloproteinase immunohistochemistry. A: Matrix metalloproteinase (MMP)-2 and MMP-9 immunostaining with DAPI and FITC filters (blue cell nuclei, green positively stained cells); B: Semi-quantitative results (aP < 0.05 vs control). DAPI: 4',6-diamidino-2-phenylindole; FITC: Fluorescein isothiocyanate.
TAV and LR-BAV hemodynamic stresses generate similar MMP activities in AA concavity tissue

MMP-2 and MMP-9 zymography results are shown in Figure 3. MMP-9 was undetectable in the zymograms. While the active form of MMP-2 was hardly detectable in the fresh controls, both latent and active MMP-2 were found in both experimental groups subjected to WSS (Figure 3A). Neither latent nor active form of MMP-9 was detected in the zymogram. Therefore, the densitometric quantification of MMP activity was only performed on MMP-2. Total MMP-2 activity was quantified as the sum of active and latent forms of MMP-2 (Figure 3B). Tissue specimens subjected to TAV AA WSS exhibited a significant increase in total MMP-2 activity relative to the fresh controls (1.5-fold increase, P = 0.02). While BAV AA WSS also resulted in increased total MMP-2 activity relative to the fresh controls (1.5-fold increase), the difference was not statistically significant (P = 0.37). No significant difference was also detected between the two experimental groups subjected to WSS (P = 0.08). Although the densitometric analysis performed on the latent form of MMP-2 (Figure 3C) indicated lower contents in groups subjected to TAV AA WSS (0.76-fold increase) and tissue subjected to BAV AA WSS (0.69-fold increase) relative to fresh tissue, the differences were not statistically significant (P = 0.17 and P = 0.12, respectively). No statistical difference was found between the two experimental groups subjected to WSS (P = 0.59). Lastly, tissue conditioning to WSS resulted in a dramatic increase in expression of active MMP-2 relative to the fresh controls, in which active MMP-2 expression was hardly detectable (TAV AA WSS: 5713-fold increase vs controls, P = 0.004; BAV AA WSS: 3877-fold increase vs controls, P = 0.0008; Figure 3D). The difference in active MMP-2 expression between the two conditioned groups remained non-significant (P = 0.15), but both groups exhibited a conversion from pro-(latent) to active MMP-2 after 48 h of conditioning.

Figure 3
Figure 3 Matrix metalloproteinase gelatin zymography. A: Zymogram showing latent and active forms of matrix metalloproteinase (MMP)-2 and MMP-9 in fresh controls and tissue conditioned to tricuspid aortic valve (TAV) ascending aorta (AA) and bicuspid aortic valve (BAV) AA wall shear stress (WSS); B: Densitometry results for total MMP-2 enzymatic activity; C: Latent MMP-2; D: Active MMP-2 (aP < 0.05 vs control; MMP-9 data not shown as MMP-9 was absent from the protein lysates).
DISCUSSION

We conducted an ex vivo study to investigate the isolated effects of BAV hemodynamic stresses on the biological remodeling of porcine AA tissue excised from the concavity of the aortic wall. The primary contribution of this study is the indication that, in the absence of any underlying congenital defect, the local hemodynamics experienced by the LR-BAV AA concavity does not trigger any acute upregulation of enzymatic protease expression or activity in the aortic medial layer.

The immunostaining and zymography analyses evidenced the absence of significant change in MMP expression and activity between the aortic wall specimens subjected to TAV AA and LR-BAV AA WSS. Those results complement our previous study on the effects of BAV flow on the biology of the AA convexity, which revealed the susceptibility of the WSS overload experienced by the convexity of the LR-BAV AA to promote aortic medial degradation via MMP-dependent pathways[34,35,40]. Those observations are consistent with the asymmetric presentation of aortic dilation observed in type-I LR-BAV patients and the higher vulnerability of the AA wall convexity to aortopathy[14,15,44]. The similarities in the hemodynamic stress environments present in the concavity of the TAV AA and LR-BAV AA evidenced in the present study, combined with the absence of difference in the remodeling activity of tissue exposed to those environments support a hemodynamic etiology of BAV aortopathy.

The demonstration of causality between the asymmetric BAV flow patterns and the asymmetric expression of secondary BAV complications has already been established in the context of BAV calcification, which typically affects primarily the fused leaflets exposed to WSS overload but spares the non-coronary leaflet subjected to relatively normal WSS levels[42,45]. Therefore, while the involvement of underlying genetic abnormalities in BAV leaflets and BAV AA tissue cannot be ruled out, the present study provides one more evidence in support of the key role played by blood flow and hemodynamic stresses in BAV disease.

While no difference in protease expression and activity was detected between the tissue groups subjected to TAV AA and BAV AA WSS, some changes were measured between the fresh controls and the conditioned groups. First, tissue subjected to WSS exhibited a significant upregulation of active MMP-2 relative to fresh tissue. Although this result requires further investigation, it is important to note that, while the bioreactor was able to subject the samples to WSS, it eliminated all other forces normally present in the native environment, such as stretch and pressure. Those forces have been shown to play a critical role in the maintenance of vascular homeostasis and MMP-2 regulation[46,47]. Second, tissue exposure to LR-BAV WSS resulted in a significant MMP-9 downregulation relative to the fresh controls as suggested by immunostaining, while MMP-2 levels remained unchanged. This difference in biological response may be related to the specific mechanosensitivity of the aortic endothelium to WSS. In fact, studies conducted in our laboratory in the context of valvular tissue have demonstrated the differential sensitivity of valvular endothelial cells to WSS magnitude, directionality and frequency[41,43,48]. Following the same concept, the cells lining the aortic wall may be able to detect changes in different WSS characteristics and transduce them into different biological responses. As a result, despite the qualitative similarity between the WSS waveforms captured in the concavity of the TAV AA and LR-BAV AA, the minor differences in magnitude and directionality, as quantified by the TSM and OSI (Table 1), may be sufficient to drive a differential biological response.

MMP-9 expression was below detection level in tissue lysates and zymograms. The near absence of MMP-9 expression following exposure of aortic concavity tissue to WSS proves to be an interesting phenomenon. Animal models have indicated that MMP-2 and MMP-9 work synergistically to promote aneurysm formation[49] and that MMP-9 knockout mice are unable to develop aneurysms even under the presence of increased MMP-2 activity[50]. Therefore, the absence of MMP-9 in fresh tissue and tissue subjected to TAV AA and BAV AA WSS, which prevents the possible downstream pathological effects of MMP-2/MMP-9 synergies, may protect the aortic wall against dilation and aneurysm formation. Further ex vivo investigations on the combined effects of WSS, MMP-2 and MMP-9 and the modulation of the remodeling response through MMP-2/MMP-9 synergies will be necessary to test this hypothesis.

Although relationships between WSS abnormalities and biological perturbations in the aortic endothelium have been previously evidenced[51-54], more work needs to be done to isolate the impact of hemodynamic stress abnormalities on tissue remodeling. The results collected from the present study combined with those from our previous study[35] on the local effects of TAV and LR-BAV AA hemodynamic stresses on AA remodeling suggest the susceptibility of BAV hemodynamic stresses to mediate aortic medial degradation on the disease-prone wall convexity, while sparing the wall concavity. These observations suggest a critical role played by hemodynamic stresses in the development of BAV asymmetric aortopathies.

Finally, several limitations should be discussed.

The demonstration of a role for WSS in the differential remodeling state of the BAV AA convexity and concavity relied on the retrospective comparison of the present data obtained with AA concavity tissue with our previous data obtained with AA convexity tissue[35]. While ideally both sets of experiments should have been carried out using tissue specimens from the same animal, the availability of a single shear stress bioreactor prevented such mode of operation. However, the same methodology (sample size, culture techniques, biological endpoints, assays) as in the previous study was implemented to allow for the direct comparison of the results.

Second, the study only focused on the effects of WSS and neglected other important mechanical signals (stretch, pressure) normally found in the native environment. This choice is justified by two arguments. First, the objective of the study was to isolate the potential role played by WSS in the remodeling of the BAV AA concavity, in the absence of any other biochemical and mechanical signals. Second, the mechanical characterization of the TAV and BAV aortic wall provided by the FSI model revealed the absence of substantial differences in circumferential stretch and pressure between the TAV AA and BAV AA (average pressure difference: 0.4% in the convexity and 0.5% in the concavity; average stretch difference: 0% in the convexity and 0.3% in the concavity). The analysis of the WSS in both anatomies revealed more contrasted environments (TSM difference: 94% in the convexity and 38% in the concavity), which motivated and justified the investigation of their mechanobiological impact.

Third, while the study would benefit from a larger sample size, the absence of significant differences in the remodeling response of TAV AA and BAV AA concavity tissue is in agreement with the data reported in larger clinical studies that examined the asymmetric nature of aortic dilation and the spatiotemporal patterns of MMP expression in BAV AAs[14-16,55,56]. In addition, the same sample size in our previous study was able to demonstrate statistically significant biological differences between convexity specimens subjected to TAV AA and BAV AA WSS. In this context, the absence of statistical differences in the remodeling response of concavity tissue samples subjected to TAV AA and BAV AA flow is likely to be a reflection of the low impact of the concavity WSS environment on the local tissue biology rather than the consequence of a small sample size.

COMMENTS
Background

The asymmetric dilation of the ascending aortic (AA) wall downstream of the bicuspid aortic valve (BAV) is marked by aortic medial degeneration through upregulation of matrix metalloproteinase (MMP) expression and enzymatic activity. BAV AA dilation typically localizes to the AA wall convexity, which is the region impinged by the skewed BAV orifice jet and subjected to abnormally high hemodynamic wall shear stress (WSS). While previous studies have established a link between the WSS overload on the AA wall convexity and the upregulation of remodeling activity, the ability of the hemodynamic environment present in the BAV AA concavity to maintain vascular homeostasis has not been formally demonstrated.

Research frontiers

The common classification of BAV aortopathy as an inherited disorder has guided the implementation of aggressive surgical modalities including reduction aortoplasty, aortic root replacement and AA replacement. However, those procedures have been associated with a significant mortality rate when treating aortic dilation in BAV patients. Such outcome questions the suitability of those surgical approaches and justifies the need to elucidate the etiology of BAV aortopathy. The characterization of the remodelling pathways involved in the disease and the interacting mechanisms of micro-scale mechanotransduction and macro-scale hemodynamics are current hotspots in BAV and vascular research.

Innovations and breakthroughs

The authors’ previous ex vivo characterization of the isolated effects of tricuspid aortic valve (TAV) AA and BAV AA WSS on the biology of the AA convexity revealed the ability of BAV AA hemodynamic abnormalities in the wall convexity to promote aortic medial degeneration via MMP-2 and MMP-9-dependent pathways. The present study is a logical extension of the authors’ previous work as it investigates the contribution of the WSS environment in the seemingly disease-protected concavity of the LR-BAV AA on MMP biology. The absence of difference in the remodeling response of tissue subjected to the local WSS normally present in the TAV AA and LR-BAV AA concavity justify at least partially the asymmetric dilation pattern typically observed in LR-BAV patients and isolate, for the first time, the key role played by hemodynamic stresses in BAV aortopathogenesis.

Applications

The demonstration of a hemodynamic pathway of BAV aortic dilation may switch the clinical focus from developing aggressive surgical procedures aimed at eliminating the presumed genetically weakened AA wall to investigating new modalities aimed at normalizing BAV aorta hemodynamics or inhibiting pharmacologically the pathological remodeling cascade at an early age.

Terminology

The BAV is the most common cardiac anomaly and consists of two leaflets instead of the three present in the normal TAV. The most common LR-BAV morphotype results from the fusion between the left- and right-coronary cusps. WSS is the frictional fluid force resulting from the relative motion between the aortic wall and the surrounding blood flow. MMP-2 and MMP-9 are two proteolytic enzymes that degrade collagen, elastin and fibronectin, which are fundamental protein components of the aortic media.

Peer-review

The manuscript by Atkins et al proposes an ex-vivo model of wall shear stress applied to the lesser curvature (concavity) of porcine thoracic aorta. The ex-vivo model reproduces in a bioreactor the shear stress generated by a TAV and by a LR-BAV, with the aim of dissecting the role played by this single local hemodynamic factor on vascular wall remodeling of aortic concavity.

Footnotes

P- Reviewer: Forte A S- Editor: Qi Y L- Editor: A E- Editor: Wu HL

References
1.  Roberts WC. The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol. 1970;26:72-83.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 698]  [Cited by in F6Publishing: 608]  [Article Influence: 11.3]  [Reference Citation Analysis (0)]
2.  Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890-1900.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3680]  [Cited by in F6Publishing: 3561]  [Article Influence: 161.9]  [Reference Citation Analysis (1)]
3.  Ward C. Clinical significance of the bicuspid aortic valve. Heart. 2000;83:81-85.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 547]  [Cited by in F6Publishing: 524]  [Article Influence: 21.8]  [Reference Citation Analysis (0)]
4.  Padang R, Bannon PG, Jeremy R, Richmond DR, Semsarian C, Vallely M, Wilson M, Yan TD. The genetic and molecular basis of bicuspid aortic valve associated thoracic aortopathy: a link to phenotype heterogeneity. Ann Cardiothorac Surg. 2013;2:83-91.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 22]  [Reference Citation Analysis (0)]
5.  Sievers HH, Schmidtke C. A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg. 2007;133:1226-1233.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 723]  [Cited by in F6Publishing: 780]  [Article Influence: 45.9]  [Reference Citation Analysis (0)]
6.  Braverman AC, Güven H, Beardslee MA, Makan M, Kates AM, Moon MR. The bicuspid aortic valve. Curr Probl Cardiol. 2005;30:470-522.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 287]  [Cited by in F6Publishing: 266]  [Article Influence: 14.0]  [Reference Citation Analysis (0)]
7.  De Mozzi P, Longo UG, Galanti G, Maffulli N. Bicuspid aortic valve: a literature review and its impact on sport activity. Br Med Bull. 2008;85:63-85.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 36]  [Cited by in F6Publishing: 43]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
8.  Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111:920-925.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 656]  [Cited by in F6Publishing: 621]  [Article Influence: 32.7]  [Reference Citation Analysis (0)]
9.  Sabet HY, Edwards WD, Tazelaar HD, Daly RC. Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2,715 additional cases. Mayo Clin Proc. 1999;74:14-26.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 2]  [Reference Citation Analysis (0)]
10.  Fernandes SM, Sanders SP, Khairy P, Jenkins KJ, Gauvreau K, Lang P, Simonds H, Colan SD. Morphology of bicuspid aortic valve in children and adolescents. J Am Coll Cardiol. 2004;44:1648-1651.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 178]  [Cited by in F6Publishing: 158]  [Article Influence: 7.9]  [Reference Citation Analysis (0)]
11.  Fedak PW, Verma S, David TE, Leask RL, Weisel RD, Butany J. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation. 2002;106:900-904.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 569]  [Cited by in F6Publishing: 511]  [Article Influence: 23.2]  [Reference Citation Analysis (0)]
12.  Khoo C, Cheung C, Jue J. Patterns of aortic dilatation in bicuspid aortic valve-associated aortopathy. J Am Soc Echocardiogr. 2013;26:600-605.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 33]  [Cited by in F6Publishing: 35]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
13.  Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005-1011.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3079]  [Cited by in F6Publishing: 3146]  [Article Influence: 174.8]  [Reference Citation Analysis (0)]
14.  Cotrufo M, Della Corte A, De Santo LS, Quarto C, De Feo M, Romano G, Amarelli C, Scardone M, Di Meglio F, Guerra G. Different patterns of extracellular matrix protein expression in the convexity and the concavity of the dilated aorta with bicuspid aortic valve: preliminary results. J Thorac Cardiovasc Surg. 2005;130:504-511.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 98]  [Cited by in F6Publishing: 89]  [Article Influence: 4.7]  [Reference Citation Analysis (0)]
15.  Della Corte A, Quarto C, Bancone C, Castaldo C, Di Meglio F, Nurzynska D, De Santo LS, De Feo M, Scardone M, Montagnani S. Spatiotemporal patterns of smooth muscle cell changes in ascending aortic dilatation with bicuspid and tricuspid aortic valve stenosis: focus on cell-matrix signaling. J Thorac Cardiovasc Surg. 2008;135:8-18, 18.e1-2.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 124]  [Cited by in F6Publishing: 138]  [Article Influence: 8.1]  [Reference Citation Analysis (0)]
16.  Ikonomidis JS, Jones JA, Barbour JR, Stroud RE, Clark LL, Kaplan BS, Zeeshan A, Bavaria JE, Gorman JH, Spinale FG. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves. J Thorac Cardiovasc Surg. 2007;133:1028-1036.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 153]  [Cited by in F6Publishing: 145]  [Article Influence: 8.5]  [Reference Citation Analysis (0)]
17.  Agozzino L, Ferraraccio F, Esposito S, Trocciola A, Parente A, Della Corte A, De Feo M, Cotrufo M. Medial degeneration does not involve uniformly the whole ascending aorta: morphological, biochemical and clinical correlations. Eur J Cardiothorac Surg. 2002;21:675-682.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 23]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
18.  Boyum J, Fellinger EK, Schmoker JD, Trombley L, McPartland K, Ittleman FP, Howard AB. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. J Thorac Cardiovasc Surg. 2004;127:686-691.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 95]  [Cited by in F6Publishing: 81]  [Article Influence: 4.1]  [Reference Citation Analysis (0)]
19.  Fedak PW, de Sa MP, Verma S, Nili N, Kazemian P, Butany J, Strauss BH, Weisel RD, David TE. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J Thorac Cardiovasc Surg. 2003;126:797-806.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 320]  [Cited by in F6Publishing: 299]  [Article Influence: 14.2]  [Reference Citation Analysis (0)]
20.  Nataatmadja M, West M, West J, Summers K, Walker P, Nagata M, Watanabe T. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation. 2003;108 Suppl 1:II329-II334.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 123]  [Cited by in F6Publishing: 159]  [Article Influence: 7.6]  [Reference Citation Analysis (0)]
21.  LeMaire SA, Wang X, Wilks JA, Carter SA, Wen S, Won T, Leonardelli D, Anand G, Conklin LD, Wang XL. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. J Surg Res. 2005;123:40-48.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 135]  [Cited by in F6Publishing: 118]  [Article Influence: 6.2]  [Reference Citation Analysis (0)]
22.  Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4:197-250.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2113]  [Cited by in F6Publishing: 2131]  [Article Influence: 68.7]  [Reference Citation Analysis (0)]
23.  Sluijter JP, de Kleijn DP, Pasterkamp G. Vascular remodeling and protease inhibition--bench to bedside. Cardiovasc Res. 2006;69:595-603.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 78]  [Cited by in F6Publishing: 71]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
24.  Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863-868.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 578]  [Cited by in F6Publishing: 602]  [Article Influence: 20.8]  [Reference Citation Analysis (0)]
25.  Chandra S, Rajamannan NM, Sucosky P. Computational assessment of bicuspid aortic valve wall-shear stress: implications for calcific aortic valve disease. Biomech Model Mechanobiol. 2012;11:1085-1096.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 91]  [Cited by in F6Publishing: 80]  [Article Influence: 7.3]  [Reference Citation Analysis (0)]
26.  Seaman C, Akingba AG, Sucosky P. Steady flow hemodynamic and energy loss measurements in normal and simulated calcified tricuspid and bicuspid aortic valves. J Biomech Eng. 2014;136.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 25]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
27.  Seaman C, Sucosky P. Anatomic versus effective orifice area in a bicuspid aortic valve. Echocardiography. 2014;31:1028.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 7]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
28.  Cao K, Sucosky P. Effect of Bicuspid Aortic Valve Cusp Fusion on Aorta Wall Shear Stress: Preliminary Computational Assessment and Implication for Aortic Dilation. World J Cardiovasc Dis. 2015;5:129-140.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 18]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
29.  van Ooij P, Potters WV, Collins J, Carr M, Carr J, Malaisrie SC, Fedak PW, McCarthy PM, Markl M, Barker AJ. Characterization of abnormal wall shear stress using 4D flow MRI in human bicuspid aortopathy. Ann Biomed Eng. 2015;43:1385-1397.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 65]  [Cited by in F6Publishing: 77]  [Article Influence: 7.7]  [Reference Citation Analysis (0)]
30.  Mahadevia R, Barker AJ, Schnell S, Entezari P, Kansal P, Fedak PW, Malaisrie SC, McCarthy P, Collins J, Carr J. Bicuspid aortic cusp fusion morphology alters aortic three-dimensional outflow patterns, wall shear stress, and expression of aortopathy. Circulation. 2014;129:673-682.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 285]  [Cited by in F6Publishing: 311]  [Article Influence: 28.3]  [Reference Citation Analysis (0)]
31.  Hope MD, Meadows AK, Hope TA, Ordovas KG, Reddy GP, Alley MT, Higgins CB. Images in cardiovascular medicine. Evaluation of bicuspid aortic valve and aortic coarctation with 4D flow magnetic resonance imaging. Circulation. 2008;117:2818-2819.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 51]  [Cited by in F6Publishing: 52]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
32.  Barker AJ, Markl M. The role of hemodynamics in bicuspid aortic valve disease. Eur J Cardiothorac Surg. 2011;39:805-806.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 36]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
33.  Girdauskas E, Disha K, Borger MA, Kuntze T. Relation of bicuspid aortic valve morphology to the dilatation pattern of the proximal aorta: focus on the transvalvular flow. Cardiol Res Pract. 2012;2012:478259.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 21]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
34.  Atkins SK, Sucosky P. Etiology of bicuspid aortic valve disease: Focus on hemodynamics. World J Cardiol. 2014;6:1227-1233.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 48]  [Article Influence: 4.8]  [Reference Citation Analysis (0)]
35.  Atkins SK, Cao K, Rajamannan NM, Sucosky P. Bicuspid aortic valve hemodynamics induces abnormal medial remodeling in the convexity of porcine ascending aortas. Biomech Model Mechanobiol. 2014;13:1209-1225.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 50]  [Cited by in F6Publishing: 53]  [Article Influence: 5.3]  [Reference Citation Analysis (0)]
36.  Sucosky P, Padala M, Elhammali A, Balachandran K, Jo H, Yoganathan AP. Design of an ex vivo culture system to investigate the effects of shear stress on cardiovascular tissue. J Biomech Eng. 2008;130:035001.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 48]  [Cited by in F6Publishing: 51]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
37.  Sun L, Rajamannan NM, Sucosky P. Design and validation of a novel bioreactor to subject aortic valve leaflets to side-specific shear stress. Ann Biomed Eng. 2011;39:2174-2185.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 36]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
38.  Sucosky P, Balachandran K, Elhammali A, Jo H, Yoganathan AP. Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF-beta1-dependent pathway. Arterioscler Thromb Vasc Biol. 2009;29:254-260.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 182]  [Cited by in F6Publishing: 183]  [Article Influence: 11.4]  [Reference Citation Analysis (0)]
39.  Braverman AC. Bicuspid aortic valve and associated aortic wall abnormalities. Curr Opin Cardiol. 1996;11:501-503.  [PubMed]  [DOI]  [Cited in This Article: ]
40.  Sucosky P. Hemodynamic Mechanisms of Bicuspid Aortic Valve Calcification and Aortopathy. Molecular Biology of Valvular Heart Disease. London: Springer 2014; 81-94.  [PubMed]  [DOI]  [Cited in This Article: ]
41.  Hoehn D, Sun L, Sucosky P. Role of Pathologic Shear Stress Alterations in Aortic Valve Endothelial Activation. Cardiovasc Eng Technol. 2010;1:165-678.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 13]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
42.  Sun L, Chandra S, Sucosky P. Ex vivo evidence for the contribution of hemodynamic shear stress abnormalities to the early pathogenesis of calcific bicuspid aortic valve disease. PLoS One. 2012;7:e48843.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 63]  [Cited by in F6Publishing: 68]  [Article Influence: 5.7]  [Reference Citation Analysis (0)]
43.  Sun L, Sucosky P. Bone morphogenetic protein-4 and transforming growth factor-beta1 mechanisms in acute valvular response to supra-physiologic hemodynamic stresses. World J Cardiol. 2015;7:331-343.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 11]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
44.  Guzzardi DG, Barker AJ, van Ooij P, Malaisrie SC, Puthumana JJ, Belke DD, Mewhort HE, Svystonyuk DA, Kang S, Verma S. Valve-Related Hemodynamics Mediate Human Bicuspid Aortopathy: Insights From Wall Shear Stress Mapping. J Am Coll Cardiol. 2015;66:892-900.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 293]  [Cited by in F6Publishing: 328]  [Article Influence: 36.4]  [Reference Citation Analysis (0)]
45.  Sucosky P, Rajamannan NM. Bicuspid Aortic Valve Disease: From Bench to Bedside. Cardiac Valvular Medicine. London: Springer; 2013; 17-21.  [PubMed]  [DOI]  [Cited in This Article: ]
46.  Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm. 2013;2013:928315.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 235]  [Cited by in F6Publishing: 279]  [Article Influence: 25.4]  [Reference Citation Analysis (0)]
47.  Ruddy JM, Jones JA, Stroud RE, Mukherjee R, Spinale FG, Ikonomidis JS. Differential effects of mechanical and biological stimuli on matrix metalloproteinase promoter activation in the thoracic aorta. Circulation. 2009;120:S262-S268.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 42]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
48.  Sun L, Rajamannan NM, Sucosky P. Defining the role of fluid shear stress in the expression of early signaling markers for calcific aortic valve disease. PLoS One. 2013;8:e84433.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in F6Publishing: 60]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
49.  Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002;110:625-632.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 366]  [Article Influence: 16.6]  [Reference Citation Analysis (0)]
50.  Ikonomidis JS, Barbour JR, Amani Z, Stroud RE, Herron AR, McClister DM, Camens SE, Lindsey ML, Mukherjee R, Spinale FG. Effects of deletion of the matrix metalloproteinase 9 gene on development of murine thoracic aortic aneurysms. Circulation. 2005;112:I242-I248.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 38]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
51.  Dolan JM, Meng H, Singh S, Paluch R, Kolega J. High fluid shear stress and spatial shear stress gradients affect endothelial proliferation, survival, and alignment. Ann Biomed Eng. 2011;39:1620-1631.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 115]  [Cited by in F6Publishing: 114]  [Article Influence: 8.8]  [Reference Citation Analysis (0)]
52.  Li YS, Haga JH, Chien S. Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomech. 2005;38:1949-1971.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 591]  [Cited by in F6Publishing: 602]  [Article Influence: 31.7]  [Reference Citation Analysis (0)]
53.  Lehoux S, Tedgui A. Signal transduction of mechanical stresses in the vascular wall. Hypertension. 1998;32:338-345.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 196]  [Cited by in F6Publishing: 201]  [Article Influence: 7.7]  [Reference Citation Analysis (0)]
54.  Ohashi T, Sato M. Remodeling of vascular endothelial cells exposed to fluid shear stress: experimental and numerical approach. Fluid Dyn Res. 2005;37:40-59.  [PubMed]  [DOI]  [Cited in This Article: ]
55.  Della Corte A, Romano G, Tizzano F, Amarelli C, De Santo LS, De Feo M, Scardone M, Dialetto G, Covino FE, Cotrufo M. Echocardiographic anatomy of ascending aorta dilatation: correlations with aortic valve morphology and function. Int J Cardiol. 2006;113:320-326.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 28]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
56.  Lu MT, Thadani SR, Hope MD. Quantitative assessment of asymmetric aortic dilation with valve-related aortic disease. Acad Radiol. 2013;20:10-15.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 14]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]